Chondroitin sulfate/xanthan gum - Laboratorios Sophia

Drug Profile

Chondroitin sulfate/xanthan gum - Laboratorios Sophia

Alternative Names: CS/XG; PRO 148

Latest Information Update: 09 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Laboratorios Sophia
  • Class Eye disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Dry eyes

Most Recent Events

  • 09 Sep 2016 Phase-III development is ongoing in Mexico
  • 01 Nov 2013 Phase-III clinical trials in Dry eyes in Mexico (Ophthalmic)
  • 03 Aug 2012 Laboratorios Sophia plans a phase III trial for Dry eyes in Mexico (NCT01657253)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top